Skip to main content
 

Our latest collaborative pub with Jenny Ting in the Lineberber Comprehensive Cancer Center is in JCI Insight. https://insight.jci.org/articles/view/120638# – ‘A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer’

Comments are closed.